-
Erastin: Benchmark Ferroptosis Inducer for Cancer Biology Re
2026-06-13
Erastin enables selective, robust induction of ferroptosis in RAS/BRAF-mutant tumor cells, empowering advanced oxidative stress assays and cancer vulnerability studies. Dive into protocol refinements, real-world troubleshooting, and the translational bridge between plant and mammalian ferroptosis uncovered by recent research.
-
Sildenafil Citrate: Advanced cGMP-Specific PDE5 Inhibitor Wo
2026-06-12
Discover how Sildenafil Citrate, a potent cGMP-specific phosphodiesterase type 5 inhibitor, is transforming proteoform-resolved vascular research and signal transduction assays. This article delivers actionable protocols, key innovations from recent proteomics studies, and troubleshooting strategies for maximizing selectivity and reproducibility in complex biological systems.
-
Puromycin dihydrochloride: Technical Guidance for Lab Select
2026-06-12
Puromycin dihydrochloride is an aminonucleoside antibiotic widely used for selecting and maintaining stable cell lines expressing the pac gene, as well as for studying protein synthesis and ribosome function. It is not suitable for experiments requiring intact translation or those using cell types with unknown sensitivity to puromycin selection. Carefully titrated use is essential to avoid nonspecific cytotoxicity.
-
EdU Imaging Kits (488): Precision S-Phase DNA Synthesis Meas
2026-06-11
EdU Imaging Kits (488) enable rapid, gentle, and highly sensitive detection of cell proliferation via click chemistry, outperforming traditional BrdU assays. This article translates the latest research and real-world workflows into actionable protocols, troubleshooting strategies, and comparative insights for high-throughput fluorescence microscopy and flow cytometry.
-
Capsaicin as a Dual TRPV1 Activator and KDM1A Inhibitor: Mec
2026-06-11
Explore how Capsaicin, a dual TRPV1 activator and KDM1A/LSD1 inhibitor, is reshaping precision research in pain, inflammation, and oncology models. This article offers a mechanistic deep dive, protocol guidance, and unique insights beyond standard applications.
-
Applied Workflows with the Cell Senescence β-Galactosidase S
2026-06-10
Unlock high-specificity detection of senescent cells with the Cell Senescence β-Galactosidase Staining Kit—engineered for artifact-free workflows and reproducible results. Explore advanced assay strategies, troubleshooting insights, and actionable parameters that accelerate cellular senescence research across disease models.
-
ROS-Responsive Nanoparticles Induce Cuproptosis for Cancer I
2026-06-10
This study pioneers a ROS-responsive nanomedicine platform for efficient induction of cuproptosis in cancer cells, combining elesclomol and copper within nanoparticles. By integrating this strategy with αPD-L1 immunotherapy, the research demonstrates enhanced tumor cell killing and immune activation, offering a novel direction for cancer treatment.
-
Partial BACE1 Inhibition Lowers Amyloid-β Without Synaptic L
2026-06-09
Satir et al. (2020) provide evidence that moderate inhibition of BACE1—resulting in less than 50% reduction of amyloid-β production—does not impair synaptic transmission in cultured neurons. This finding refines the safety threshold for BACE1 inhibitors, guiding Alzheimer's disease research on optimal dosing strategies.
-
NLRP10 Regulates Epidermal Homeostasis and Barrier Function
2026-06-09
This study elucidates the role of NLRP10 in maintaining skin barrier integrity by supporting keratinocyte survival and differentiation via p63 stabilization. The findings highlight NLRP10 downregulation as a key factor in atopic dermatitis pathogenesis and suggest new therapeutic avenues for restoring epidermal homeostasis.
-
(+)-Bicuculline: Technical Workflow Guide for GABAA Antagoni
2026-06-08
(+)-Bicuculline is a well-established GABAA receptor antagonist used to dissect inhibitory neurotransmission and modulate synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic or clinical applications, and demands precise handling—especially regarding solubility and storage—to ensure experimental reliability.
-
Neurotensin: Precision Neurotensin Receptor 1 Activator Work
2026-06-08
Neurotensin enables unparalleled control over GPCR trafficking and miRNA regulation studies in gastrointestinal and neural models. By leveraging APExBIO’s high-purity peptide and evidence-based protocols, researchers can achieve robust experimental reproducibility and streamlined troubleshooting, even when facing spectral interference.
-
Streptavidin-HyperFluor 647: Elevating Biotin Detection Work
2026-06-07
Streptavidin-HyperFluor 647 sets a new benchmark for sensitive, low-background detection of biotinylated molecules in advanced proteomic workflows. Its unique conjugate design enables robust performance across fluorescence microscopy, flow cytometry, and FRET, especially where signal-to-noise is paramount. Discover how to unlock its full potential through optimized protocols and troubleshooting guidance.
-
RP3-340N1.2 Knockdown Impairs NSCLC Growth via IL-6 Regulati
2026-06-06
This study uncovers how the lncRNA RP3-340N1.2 promotes non-small cell lung cancer (NSCLC) progression by stabilizing IL-6 mRNA, thereby sustaining tumor cell proliferation and migration. Through targeted knockdown and mechanistic assays, the research demonstrates that inhibiting RP3-340N1.2 disrupts pro-tumorigenic signaling, highlighting a novel RNA-based vulnerability in NSCLC.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Protocols & Best Us
2026-06-05
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive, specific detection of rabbit IgG in fluorescence-based immunoassays, supporting applications such as immunofluorescence, IHC, and ICC. It is not intended for diagnostic, clinical, or non-rabbit primary antibody workflows. Adhering to recommended protocols and storage conditions is essential for reproducible results.
-
CHI3L1-IN-5 (Compound Z17): Selective NF-κB Pathway Inhibito
2026-06-05
CHI3L1-IN-5 (Compound Z17) is a potent, selective inhibitor of CHI3L1 with nanomolar binding affinity and robust CNS penetration. It blocks CHI3L1-mediated NF-κB signaling and restores astrocyte function impaired by amyloid-β. These properties position it as a promising tool and candidate for Alzheimer’s disease research.